DB12497InvestigationalSmall molecule
Alagebrium has been investigated for the treatment and prevention of Aging, Heart Failure, Physical Activity, Diabetic Nephropathy, and Cardiovascular Disease, among others.
- Formula / weight
- C13H14NOS · 232.32 g/mol (avg)
Resolves to
Structure
InChIKey
LYLFQLCLUXOFOL-UHFFFAOYSA-NSMILESCC1=C(C)[N+](CC(=O)C2=CC=CC=C2)=CS1What you can answer from here — as of April 02, 2025
Which companies are running trials of Alagebrium, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account